Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
865,10 €
0,63 %
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Guggenheim from $973.00 to $928.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating and a $975.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was downgraded by analysts at HSBC Holdings plc from a "buy" rating to a "reduce" rating. They now have a $700.00 price target on the stock, down previously from $1,150.00.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Guggenheim. They now have a $936.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Morgan Stanley.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Guggenheim from $936.00 to $942.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at UBS Group AG from $1,050.00 to $895.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Deutsche Bank Aktiengesellschaft from $1,010.00 to $900.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target lowered by analysts at Guggenheim from $942.00 to $875.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was given a new $825.00 price target on by analysts at Cantor Fitzgerald. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) was upgraded by analysts at DZ Bank AG from a "hold" rating to a "strong-buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) had its price target lowered by analysts at JPMorgan Chase & Co. from $1,100.00 to $1,050.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at Guggenheim from $875.00 to $948.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) was given a new $925.00 price target on by analysts at Cantor Fitzgerald. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $876.00 to $879.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) was upgraded by analysts at Erste Group Bank AG from a "hold" rating to a "buy" rating.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at Guggenheim. They now have a $948.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at BMO Capital Markets from $840.00 to $930.00. They now have an "outperform" rating on the stock.
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
Citigroup_Inc_ in Northrop Grumman Corp. diskutieren